Masataka Nakano, MD

Original Contribution

Preclinical Evaluation of Second-Generation Everolimus- and Zotarolimus-Eluting Coronary Stents

07/30/2013

Saami K. Yazdani , PhD;

Alexander Sheehy ;

Marc Vorpahl , MD;

Masataka Nakano , MD;

Fumiyuki Otsuka , MD, PhD;

Gaku Nakazawa , MD;

Charles A. Simonton III, MD;

Rosy S. Donn ;

Laura E. Perkins , DVM, PhD;

Renu Virmani , MD, PhD;

Frank D. Kolodgie , PhD;

Second-generation DES have alleviated the safety concerns of late stent thrombosis by addressing issues of polymer biocompatibility, stent design and optimizing drug loads and release kinetics. This study was designed to evaluate the...

Second-generation DES have...

07/30/2013

Journal of Invasive Cardiology

Original Contribution

The Efficacy and Feasibility of Chronic Total Occlusion by Transradial Intervention: A Japanese Single-Center Retrospective Study

09/02/2015

Khalid O. Tammam , MD, PhD;

Tsutomu Murakami , MD;

Sho Torii , MD;

Takeshi Ijichi , MD;

Makoto Natsumeda , MD, PhD;

Fuminobu Yoshimachi , MD, PhD;

Toshiharu Fujii , MD, PhD;

Takashi Matsukage , MD, PhD;

Masataka Nakano , MD;

Yuji Ikari , MD, PhD, FACC, FESC;

Yohei Ohno , MD;

Naoki Masuda , MD;

Norihiko Shinozaki , MD, PhD;

Nobuhiko Ogata , MD, PhD;

Gaku Nakazawa , MD;

We retrospectively analyzed 207 CTO lesions in 195 patients in a single center between January 2008 and December 2011 and found that over one-half of CTO lesions can be treated with high success and low complication rates by TRI if the...

We retrospectively analyzed 207...

09/02/2015

Journal of Invasive Cardiology